ESC 365 - Gender differences in the treatment with PCSK9 monoclonal antibodies real world experience from a dedicated prevention clinic

ESC Premium Access

Gender differences in the treatment with PCSK9 monoclonal antibodies real world experience from a dedicated prevention clinic

Session: Gender differences in heart disease

Topic: Drug therapy

Speaker: Doctor L. Hodeda (Petah Tikva, IL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Lital Hodeda

Rabin Medical Center, Petah Tikva (Israel)

0 follower

5 more presentations in this session

Gender disparities and infective endocarditis burden in the United States and European Union: a comparative analysis

Speaker: Doctor M. Petrovic (New York, US)

Traditional cardiovascular risk factors and coronary microvascular disease in women and men- a single center study

Speaker: Doctor L. Zornitzki (Tel Aviv, IL)

Interaction between subclinical carotid atherosclerosis endotype and biological sex: a study from IMPROVE cohort

Speaker: Mr Q. Chen (Stockholm, SE)

Is there a gender difference in the effects of cardiovascular risk factors on the anatomical localization and severity of obstruction on coronary arteries?

Speaker: Doctor A. Erdem (Istanbul, TR)

Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland.

Speaker: Doctor T. Pana (Aberdeen, GB)

Access the full session

Gender differences in heart disease

Speakers: Doctor L. Hodeda, Doctor M. Petrovic, Doctor L. Zornitzki, Mr Q. Chen, Doctor A. Erdem...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources